<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="06/04/2006" creator="Yo Shidahara" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=1768652">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>1768652</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term sem="Protein_family_or_group" id="T1" lex="kappa_B-specific_DNA_binding_protein"><term sem="DNA_domain_or_region" id="A101">Kappa B</term>-specific DNA binding <term sem="Protein_family_or_group" id="A102">proteins</term></term> are differentially inhibited by <term sem="Other" id="T2" lex="enhancer_mutation"><term sem="DNA_domain_or_region" id="A1">enhancer</term> mutations</term> and <term sem="Other" id="T3" lex="biological_oxidation">biological oxidation</term>.</sentence>
<event id="E1">
<type class="Mutagenesis" />
<theme idref="A1" />
<clue>Kappa B-specific DNA binding proteins are differentially inhibited by enhancer <clueType>mutations</clueType> and biological oxidation.</clue>
<comment>ARTIFICIAL</comment>
</event>
<event id="E2">
<type class="Negative_regulation" />
<theme idref="T1" />
<cause idref="E1" />
<clue>Kappa B-specific DNA binding proteins are differentially <clueType>inhibited</clueType> <linkCause>by</linkCause> enhancer mutations and biological oxidation.</clue>
</event>
<event id="E3">
<type class="Negative_regulation" />
<theme idref="T1" />
<cause idref="T3" />
<clue>Kappa B-specific DNA binding proteins are differentially <clueType>inhibited</clueType> <linkCause>by</linkCause> enhancer mutations and biological oxidation.</clue>
</event>
<event id="E101">
<type class="Binding" />
<theme idref="A101" />
<theme idref="A102" />
<clue>Kappa B-<linkTheme>specific</linkTheme> DNA <clueType>binding</clueType> proteins are differentially inhibited by enhancer mutations and biological oxidation.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term sem="Protein_family_or_group" id="T4" lex="kappa_B_(kappa_B)_enhancer_binding_protein"><term sem="DNA_domain_or_region" id="A103">Kappa B (kappa B) enhancer</term> binding <term sem="Protein_family_or_group" id="A104">proteins</term></term> isolated from the nuclei of activated <term sem="Cell_natural" id="T5" lex="human_T_cell">human T cells</term> produce two distinct <term sem="Protein_complex" id="T6" lex="nucleoprotein_complex">nucleoprotein complexes</term> when incubated with the <term sem="DNA_domain_or_region" id="T7" lex="kappa_B_element">kappa B element</term> from the <term sem="DNA_domain_or_region" id="T8" lex="interleukin-2_receptor-alpha_(IL-2R_alpha)_gene">interleukin-2 receptor-alpha (<term sem="Protein_molecule" id="T9" lex="IL-2R_alpha">IL-2R alpha</term>) gene</term>.</sentence>
<event id="E4">
<type class="Binding" />
<theme idref="T4" />
<theme idref="T7" />
<clue>Kappa B (kappa B) enhancer binding proteins isolated from the nuclei of activated human T cells <clueType>produce</clueType> two distinct nucleoprotein <clueType>complexes</clueType> <linkTheme>when incubated with</linkTheme> the kappa B element from the interleukin-2 receptor-alpha (IL-2R alpha) gene.</clue>
</event>
<event id="E102">
<type class="Binding" />
<theme idref="A103" />
<theme idref="A104" />
<clue>Kappa B (kappa B) enhancer <clueType>binding</clueType> proteins isolated from the nuclei of activated human T cells produce two distinct nucleoprotein complexes when incubated with the kappa B element from the interleukin-2 receptor-alpha (IL-2R alpha) gene.</clue>
</event>
<sentence id="S3">These two <term sem="Protein_complex" id="T10" lex="DNA-protein_complex">DNA-protein complexes</term> are composed of at least four host proteins (<term sem="Protein_molecule" id="T11" lex="p50">p50</term>, <term sem="Protein_molecule" id="T12" lex="p55">p55</term>, <term sem="Protein_molecule" id="T13" lex="p75">p75</term>, <term sem="Protein_molecule" id="T14" lex="p85">p85</term>), each of which shares structural similarity with the <term sem="Protein_molecule" id="T15" lex="v-rel_oncogene_product">v-rel oncogene product</term>.</sentence>
<sentence id="S4"><term sem="Other" id="T16" lex="nuclear_expression">Nuclear expression</term> of these proteins is induced with distinctly <term sem="Other" id="T17" lex="biphasic_kinetics">biphasic kinetics</term> following <term sem="Organic_compound_other" id="T18" lex="phorbol_ester">phorbol ester</term> activation of <term sem="Cell_natural" id="T19" lex="T_cell">T cells</term> (<term sem="Protein_molecule" id="T20" lex="p55/p75_early">p55/p75 early</term> and <term sem="Protein_molecule" id="T21" lex="p50/p85_late">p50/p85 late</term>).</sentence>
<event id="E6">
<type class="Physiological_process" />
<theme idref="T19" />
<cause idref="T18" />
<clue>Nuclear expression of these proteins is induced with distinctly biphasic kinetics following phorbol ester <clueType>activation</clueType> <linkTheme>of</linkTheme> T cells (p55/p75 early and p50/p85 late).</clue>
</event>
<event id="E7">
<type class="Gene_expression" />
<theme idref="T11" />
<clue><clueLoc>Nuclear</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> <corefTheme>these proteins</corefTheme> is induced with distinctly biphasic kinetics following phorbol ester activation of T cells (p55/p75 early and p50/p85 late).</clue>
</event>
<event id="E8">
<type class="Gene_expression" />
<theme idref="T12" />
<clue><clueLoc>Nuclear</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> <corefTheme>these proteins</corefTheme> is induced with distinctly biphasic kinetics following phorbol ester activation of T cells (p55/p75 early and p50/p85 late).</clue>
</event>
<event id="E9">
<type class="Gene_expression" />
<theme idref="T13" />
<clue><clueLoc>Nuclear</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> <corefTheme>these proteins</corefTheme> is induced with distinctly biphasic kinetics following phorbol ester activation of T cells (p55/p75 early and p50/p85 late).</clue>
</event>
<event id="E10">
<type class="Gene_expression" />
<theme idref="T14" />
<clue><clueLoc>Nuclear</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> <corefTheme>these proteins</corefTheme> is induced with distinctly biphasic kinetics following phorbol ester activation of T cells (p55/p75 early and p50/p85 late).</clue>
</event>
<event id="E11">
<type class="Positive_regulation" />
<theme idref="E7" />
<cause idref="E6" />
<clue>Nuclear expression of these proteins is <clueType>induced</clueType> with distinctly biphasic kinetics <linkCause>following</linkCause> phorbol ester activation of T cells (p55/p75 early and p50/p85 late).</clue>
</event>
<event id="E12">
<type class="Positive_regulation" />
<theme idref="E8" />
<cause idref="E6" />
<clue>Nuclear expression of these proteins is <clueType>induced</clueType> with distinctly biphasic kinetics <linkCause>following</linkCause> phorbol ester activation of T cells (p55/p75 early and p50/p85 late).</clue>
</event>
<event id="E13">
<type class="Positive_regulation" />
<theme idref="E9" />
<cause idref="E6" />
<clue>Nuclear expression of these proteins is <clueType>induced</clueType> with distinctly biphasic kinetics <linkCause>following</linkCause> phorbol ester activation of T cells (p55/p75 early and p50/p85 late).</clue>
</event>
<event id="E14">
<type class="Positive_regulation" />
<theme idref="E10" />
<cause idref="E6" />
<clue>Nuclear expression of these proteins is <clueType>induced</clueType> with distinctly biphasic kinetics <linkCause>following</linkCause> phorbol ester activation of T cells (p55/p75 early and p50/p85 late).</clue>
</event>
<sentence id="S5"><term sem="Other" id="T22" lex="DNA-protein_crosslinking_study">DNA-protein crosslinking studies</term> have revealed that the more rapidly migrating <term sem="Protein_complex" id="T23" lex="B2_complex">B2 complex</term> contains both <term sem="Protein_molecule" id="T24" lex="p50">p50</term> and <term sem="Protein_molecule" id="T25" lex="p55">p55</term> while the more slowly migrating <term sem="Protein_complex" id="T26" lex="B1_complex">B1 complex</term> is composed of <term sem="Protein_molecule" id="T27" lex="p50">p50</term>, <term sem="Protein_molecule" id="T28" lex="p55">p55</term>, <term sem="Protein_molecule" id="T29" lex="p75">p75</term>, and <term sem="Protein_molecule" id="T30" lex="p85">p85</term>.</sentence>
<event id="E103">
<type class="Localization" />
<theme idref="T23" />
<clue>DNA-protein crosslinking studies have revealed that the more <clueTime>rapidly</clueTime> <clueType>migrating</clueType> B2 complex contains both p50 and p55 while the more slowly migrating B1 complex is composed of p50, p55, p75, and p85.</clue>
</event>
<event id="E104">
<type class="Localization" />
<theme idref="T26" />
<clue>DNA-protein crosslinking studies have revealed that the more rapidly migrating B2 complex contains both p50 and p55 while the more <clueTime>slowly</clueTime> <clueType>migrating</clueType> B1 complex is composed of p50, p55, p75, and p85.</clue>
</event>
<sentence id="S6">Site-directed mutagenesis of the <term sem="DNA_domain_or_region" id="T31" lex="wild-type_IL-2R_alpha_kappa_B_enhancer">wild-type IL-2R alpha kappa B enhancer</term> (<term sem="Polynucleotide" id="T32" lex="GGGGAATCTCCC">GGGGAATCTCCC</term>) has revealed that the binding of <term sem="Protein_substructure" id="T33" lex="p50">p50</term> and <term sem="Protein_molecule" id="T34" lex="p55">p55</term> (<term sem="Protein_complex" id="T35" lex="B2_complex">B2 complex</term>) is particularly sensitive to alteration of the <term sem="DNA_domain_or_region" id="A111"><term sem="DNA_domain_or_region" id="T36" lex="5&apos;_triplet">5&apos; triplet</term> of <term sem="Nucleotide" id="T37" lex="deoxyguanosine_residue">deoxyguanosine residues</term></term>.</sentence>
<event id="E18">
<type class="Binding" />
<theme idref="T33" />
<theme idref="T31" />
<clue>Site-directed mutagenesis of the wild-type IL-2R alpha kappa B enhancer (GGGGAATCTCCC) has revealed that the <clueType>binding</clueType> of p50 and p55 (B2 complex) is particularly sensitive to alteration of the 5&apos; triplet of deoxyguanosine residues.</clue>
<comment>Ner T33 mod</comment>
</event>
<event id="E19">
<type class="Binding" />
<theme idref="T34" />
<theme idref="T31" />
<clue>Site-directed mutagenesis of the wild-type IL-2R alpha kappa B enhancer (GGGGAATCTCCC) has revealed that the <clueType>binding</clueType> of p50 and p55 (B2 complex) is particularly sensitive to alteration of the 5&apos; triplet of deoxyguanosine residues.</clue>
</event>
<event id="E105">
<type class="Mutagenesis" />
<theme idref="A111" />
<clue>Site-directed mutagenesis of the wild-type IL-2R alpha kappa B enhancer (GGGGAATCTCCC) has revealed that the binding of p50 and p55 (B2 complex) is particularly sensitive to <clueType>alteration</clueType> <linkTheme>of</linkTheme> the 5&apos; triplet of deoxyguanosine residues.</clue>
<comment>TPS A111, ARTIFICIAL</comment>
</event>
<event id="E20">
<type class="Regulation" />
<theme idref="E18" />
<cause idref="E105" />
<clue><clueExperiment>Site-directed mutagenesis of the wild-type IL-2R alpha kappa B enhancer (GGGGAATCTCCC)</clueExperiment> has revealed that the binding of p50 and p55 (B2 complex) is particularly <clueType>sensitive</clueType> <linkCause>to</linkCause> alteration of the 5&apos; triplet of deoxyguanosine residues.</clue>
<comment>SENSITIVITY</comment>
</event>
<event id="E157">
<type class="Regulation" />
<theme idref="E19" />
<cause idref="E105" />
<clue><clueExperiment>Site-directed mutagenesis of the wild-type IL-2R alpha kappa B enhancer (GGGGAATCTCCC)</clueExperiment> has revealed that the binding of p50 and p55 (B2 complex) is particularly <clueType>sensitive</clueType> <linkCause>to</linkCause> alteration of the 5&apos; triplet of deoxyguanosine residues.</clue>
<comment>SENSITIVITY</comment>
</event>
<sentence id="S7">In contrast, formation of the <term sem="Protein_complex" id="T38" lex="B1_complex">B1 complex</term>, reflecting the binding of <term sem="Protein_molecule" id="T39" lex="p75">p75</term> and <term sem="Protein_molecule" id="T40" lex="p85">p85</term>, critically depends upon the more <term sem="DNA_domain_or_region" id="A2">3&apos; sequences of this <term sem="DNA_domain_or_region" id="T41" lex="enhancer_element">enhancer element</term>.</term></sentence>
<event id="E21">
<type class="Binding" />
<theme idref="T39" />
<theme idref="T31" />
<clue>In contrast, formation of the B1 complex, reflecting the <clueType>binding</clueType> <linkTheme>of</linkTheme> p75 and p85, critically depends upon the more 3&apos; sequences of <corefTheme>this enhancer element</corefTheme>.</clue>
<comment>TPS A2</comment>
</event>
<event id="E56">
<type class="Binding" />
<theme idref="T40" />
<theme idref="T31" />
<clue>In contrast, formation of the B1 complex, reflecting the <clueType>binding</clueType> <linkTheme>of</linkTheme> p75 and p85, critically depends upon the more 3&apos; sequences of <corefTheme>this enhancer element</corefTheme>.</clue>
</event>
<event id="E22">
<type class="Positive_regulation" />
<theme idref="E21" />
<cause idref="A2" />
<clue>In contrast, formation of the B1 complex, reflecting the binding of p75 and p85, critically <clueType>depends</clueType> <linkCause>upon</linkCause> the more 3&apos; sequences of this enhancer element.</clue>
</event>
<event id="E257">
<type class="Binding" />
<theme idref="T38" />
<clue>In contrast, <clueType>formation</clueType> <linkTheme>of</linkTheme> the B1 <clueType>complex</clueType>, reflecting the binding of p75 and p85, critically depends upon the more 3&apos; sequences of this enhancer element.</clue>
</event>
<event id="E258">
<type class="Positive_regulation" />
<theme idref="E56" />
<cause idref="A2" />
<clue>In contrast, formation of the B1 complex, reflecting the binding of p75 and p85, critically <clueType>depends</clueType> <linkCause>upon</linkCause> the more 3&apos; sequences of this enhancer element.</clue>
</event>
<event id="E259">
<type class="Positive_regulation" />
<theme idref="E257" />
<cause idref="A2" />
<clue>In contrast, formation of the B1 complex, reflecting the binding of p75 and p85, critically <clueType>depends</clueType> <linkCause>upon</linkCause> the more 3&apos; sequences of this enhancer element.</clue>
</event>
<sentence id="S8"><term sem="DNA_domain_or_region" id="A3">DNA</term> binding by all four of these <term sem="Protein_family_or_group" id="T42" lex="Rel-related_factor">Rel-related factors</term> is blocked by selective chemical modification of <term sem="Amino_acid_monomer" id="T43" lex="lysine">lysine</term> and <term sem="Amino_acid_monomer" id="T44" lex="arginine_residue">arginine</term> residues, suggesting that both of these <term sem="Amino_acid_monomer" id="T45" lex="basic_amino_acid">basic amino acids</term> are required for binding to the <term sem="DNA_domain_or_region" id="T46" lex="kappa_B_element">kappa B element</term>.</sentence>
<event id="E23">
<type class="Binding" />
<theme idref="A3" />
<theme idref="T27" />
<clue>DNA <clueType>binding</clueType> <linkTheme>by</linkTheme> <corefTheme>all four of these Rel-related factors</corefTheme> is blocked by selective chemical modification of lysine and arginine residues, suggesting that both of these basic amino acids are required for binding to the kappa B element.</clue>
</event>
<event id="E24">
<type class="Binding" />
<theme idref="A3" />
<theme idref="T28" />
<clue>DNA <clueType>binding</clueType> <linkTheme>by</linkTheme> <corefTheme>all four of these Rel-related factors</corefTheme> is blocked by selective chemical modification of lysine and arginine residues, suggesting that both of these basic amino acids are required for binding to the kappa B element.</clue>
</event>
<event id="E25">
<type class="Binding" />
<theme idref="A3" />
<theme idref="T29" />
<clue>DNA <clueType>binding</clueType> <linkTheme>by</linkTheme> <corefTheme>all four of these Rel-related factors</corefTheme> is blocked by selective chemical modification of lysine and arginine residues, suggesting that both of these basic amino acids are required for binding to the kappa B element.</clue>
</event>
<event id="E26">
<type class="Binding" />
<theme idref="A3" />
<theme idref="T30" />
<clue>DNA <clueType>binding</clueType> <linkTheme>by</linkTheme> <corefTheme>all four of these Rel-related factors</corefTheme> is blocked by selective chemical modification of lysine and arginine residues, suggesting that both of these basic amino acids are required for binding to the kappa B element.</clue>
</event>
<event id="E27">
<type class="Protein_modification" />
<theme idref="T42" />
 <site idref="T43" /><clue>DNA binding by all four of these Rel-related factors is blocked by selective chemical <clueType>modification</clueType> of lysine and arginine residues, suggesting that both of these basic amino acids are required for binding to the kappa B element.</clue>
</event>
<event id="E28">
<type class="Protein_modification" />
<theme idref="T42" />
 <site idref="T44" /><clue>DNA binding by all four of these Rel-related factors is blocked by selective chemical <clueType>modification</clueType> of lysine and arginine residues, suggesting that both of these basic amino acids are required for binding to the kappa B element.</clue>
<comment>NER T44 mod</comment>
</event>
<event id="E29">
<type class="Negative_regulation" />
<theme idref="E23" />
<cause idref="E27" />
<clue>DNA binding by all four of these Rel-related factors is <clueType>blocked</clueType> <linkCause>by</linkCause> selective chemical modification of lysine and arginine residues, suggesting that both of these basic amino acids are required for binding to the kappa B element.</clue>
</event>
<event id="E30">
<type class="Negative_regulation" />
<theme idref="E24" />
<cause idref="E27" />
<clue>DNA binding by all four of these Rel-related factors is <clueType>blocked</clueType> <linkCause>by</linkCause> selective chemical modification of lysine and arginine residues, suggesting that both of these basic amino acids are required for binding to the kappa B element.</clue>
</event>
<event id="E31">
<type class="Negative_regulation" />
<theme idref="E25" />
<cause idref="E27" />
<clue>DNA binding by all four of these Rel-related factors is <clueType>blocked</clueType> <linkCause>by</linkCause> selective chemical modification of lysine and arginine residues, suggesting that both of these basic amino acids are required for binding to the kappa B element.</clue>
</event>
<event id="E32">
<type class="Negative_regulation" />
<theme idref="E26" />
<cause idref="E27" />
<clue>DNA binding by all four of these Rel-related factors is <clueType>blocked</clueType> <linkCause>by</linkCause> selective chemical modification of lysine and arginine residues, suggesting that both of these basic amino acids are required for binding to the kappa B element.</clue>
</event>
<event id="E33">
<type class="Negative_regulation" />
<theme idref="E24" />
<cause idref="E28" />
<clue>DNA binding by all four of these Rel-related factors is <clueType>blocked</clueType> <linkCause>by</linkCause> selective chemical modification of lysine and arginine residues, suggesting that both of these basic amino acids are required for binding to the kappa B element.</clue>
</event>
<event id="E34">
<type class="Negative_regulation" />
<theme idref="E25" />
<cause idref="E28" />
<clue>DNA binding by all four of these Rel-related factors is <clueType>blocked</clueType> <linkCause>by</linkCause> selective chemical modification of lysine and arginine residues, suggesting that both of these basic amino acids are required for binding to the kappa B element.</clue>
</event>
<event id="E35">
<type class="Negative_regulation" />
<theme idref="E26" />
<cause idref="E28" />
<clue>DNA binding by all four of these Rel-related factors is <clueType>blocked</clueType> <linkCause>by</linkCause> selective chemical modification of lysine and arginine residues, suggesting that both of these basic amino acids are required for binding to the kappa B element.</clue>
</event>
<event id="E36">
<type class="Negative_regulation" />
<theme idref="E23" />
<cause idref="E28" />
<clue>DNA binding by all four of these Rel-related factors is <clueType>blocked</clueType> <linkCause>by</linkCause> selective chemical modification of lysine and arginine residues, suggesting that both of these basic amino acids are required for binding to the kappa B element.</clue>
</event>
<sentence id="S9">Similarly, covalent modification of free <term sem="Organic_compound_other" id="T47" lex="sulfhydryl_group">sulfhydryl groups</term> with <term sem="Organic_compound_other" id="T48" lex="diamide">diamide</term> (reversible) or <term sem="Organic_compound_other" id="T49" lex="N-ethylmaleimide">N-ethylmaleimide</term> (irreversible) results in a complete loss of <term sem="Other" id="T50" lex="DNA_binding_activity">DNA binding activity</term>.</sentence>
<event id="E37">
<type class="Protein_modification" />
<theme idref="T27" />
 <site idref="T47" /><clue>Similarly, covalent <clueType>modification</clueType> of free sulfhydryl groups with diamide (reversible) or N-ethylmaleimide (irreversible) results in a complete loss of DNA binding activity.</clue>
<comment>NO COREFTHEME</comment>
</event>
<event id="E5">
<type class="Protein_modification" />
<theme idref="T28" />
 <site idref="T47" /><clue>Similarly, covalent <clueType>modification</clueType> of free sulfhydryl groups with diamide (reversible) or N-ethylmaleimide (irreversible) results in a complete loss of DNA binding activity.</clue>
<comment>NO COREFTHEME</comment>
</event>
<event id="E15">
<type class="Protein_modification" />
<theme idref="T29" />
 <site idref="T47" /><clue>Similarly, covalent <clueType>modification</clueType> of free sulfhydryl groups with diamide (reversible) or N-ethylmaleimide (irreversible) results in a complete loss of DNA binding activity.</clue>
<comment>NO COREFTHEME</comment>
</event>
<event id="E16">
<type class="Protein_modification" />
<theme idref="T30" />
 <site idref="T47" /><clue>Similarly, covalent <clueType>modification</clueType> of free sulfhydryl groups with diamide (reversible) or N-ethylmaleimide (irreversible) results in a complete loss of DNA binding activity.</clue>
<comment>NO COREFTHEME</comment>
</event>
<event id="E17">
<type class="Positive_regulation" />
<theme idref="E37" />
<cause idref="T48" />
<clue>Similarly, covalent modification of free sulfhydryl groups <linkCause>with</linkCause> diamide (reversible) or N-ethylmaleimide (irreversible) results in a complete loss of DNA binding activity.</clue>
<comment>NO CLUETYPE</comment>
</event>
<event id="E38">
<type class="Positive_regulation" />
<theme idref="E5" />
<cause idref="T48" />
<clue>Similarly, covalent modification of free sulfhydryl groups <linkCause>with</linkCause> diamide (reversible) or N-ethylmaleimide (irreversible) results in a complete loss of DNA binding activity.</clue>
<comment>NO CLUETYPE</comment>
</event>
<event id="E42">
<type class="Positive_regulation" />
<theme idref="E15" />
<cause idref="T48" />
<clue>Similarly, covalent modification of free sulfhydryl groups <linkCause>with</linkCause> diamide (reversible) or N-ethylmaleimide (irreversible) results in a complete loss of DNA binding activity.</clue>
<comment>NO CLUETYPE</comment>
</event>
<event id="E47">
<type class="Positive_regulation" />
<theme idref="E16" />
<cause idref="T48" />
<clue>Similarly, covalent modification of free sulfhydryl groups <linkCause>with</linkCause> diamide (reversible) or N-ethylmaleimide (irreversible) results in a complete loss of DNA binding activity.</clue>
<comment>NO CLUETYPE</comment>
</event>
<event id="E50">
<type class="Positive_regulation" />
<theme idref="E37" />
<cause idref="T49" />
<clue>Similarly, covalent modification of free sulfhydryl groups <linkCause>with</linkCause> diamide (reversible) or N-ethylmaleimide (irreversible) results in a complete loss of DNA binding activity.</clue>
<comment>NO CLUETYPE</comment>
</event>
<event id="E59">
<type class="Positive_regulation" />
<theme idref="E5" />
<cause idref="T49" />
<clue>Similarly, covalent modification of free sulfhydryl groups <linkCause>with</linkCause> diamide (reversible) or N-ethylmaleimide (irreversible) results in a complete loss of DNA binding activity.</clue>
<comment>NO CLUETYPE</comment>
</event>
<event id="E60">
<type class="Positive_regulation" />
<theme idref="E15" />
<cause idref="T49" />
<clue>Similarly, covalent modification of free sulfhydryl groups <linkCause>with</linkCause> diamide (reversible) or N-ethylmaleimide (irreversible) results in a complete loss of DNA binding activity.</clue>
<comment>NO CLUETYPE</comment>
</event>
<event id="E61">
<type class="Positive_regulation" />
<theme idref="E16" />
<cause idref="T49" />
<clue>Similarly, covalent modification of free sulfhydryl groups <linkCause>with</linkCause> diamide (reversible) or N-ethylmaleimide (irreversible) results in a complete loss of DNA binding activity.</clue>
<comment>NO CLUETYPE</comment>
</event>
<event id="E39">
<type class="Negative_regulation" />
<theme idref="E23" />
<cause idref="E17" />
<clue>Similarly, covalent modification of free sulfhydryl groups with diamide (reversible) or N-ethylmaleimide (irreversible) <clueType>results in</clueType> a complete <clueType>loss</clueType> of <corefTheme>DNA binding activity</corefTheme>.</clue>
</event>
<event id="E40">
<type class="Negative_regulation" />
<theme idref="E24" />
<cause idref="E38" />
<clue>Similarly, covalent modification of free sulfhydryl groups with diamide (reversible) or N-ethylmaleimide (irreversible) <clueType>results in</clueType> a complete <clueType>loss</clueType> of <corefTheme>DNA binding activity</corefTheme>.</clue>
</event>
<event id="E57">
<type class="Negative_regulation" />
<theme idref="E25" />
<cause idref="E41" />
<clue>Similarly, covalent modification of free sulfhydryl groups with diamide (reversible) or N-ethylmaleimide (irreversible) <clueType>results in</clueType> a complete <clueType>loss</clueType> of <corefTheme>DNA binding activity</corefTheme>.</clue>
</event>
<event id="E58">
<type class="Negative_regulation" />
<theme idref="E26" />
<cause idref="E47" />
<clue>Similarly, covalent modification of free sulfhydryl groups with diamide (reversible) or N-ethylmaleimide (irreversible) <clueType>results in</clueType> a complete <clueType>loss</clueType> of <corefTheme>DNA binding activity</corefTheme>.</clue>
</event>
<event id="E62">
<type class="Negative_regulation" />
<theme idref="E23" />
<cause idref="E50" />
<clue>Similarly, covalent modification of free sulfhydryl groups with diamide (reversible) or N-ethylmaleimide (irreversible) <clueType>results in</clueType> a complete <clueType>loss</clueType> of <corefTheme>DNA binding activity</corefTheme>.</clue>
</event>
<event id="E63">
<type class="Negative_regulation" />
<theme idref="E24" />
<cause idref="E59" />
<clue>Similarly, covalent modification of free sulfhydryl groups with diamide (reversible) or N-ethylmaleimide (irreversible) <clueType>results in</clueType> a complete <clueType>loss</clueType> of <corefTheme>DNA binding activity</corefTheme>.</clue>
</event>
<event id="E64">
<type class="Negative_regulation" />
<theme idref="E25" />
<cause idref="E60" />
<clue>Similarly, covalent modification of free sulfhydryl groups with diamide (reversible) or N-ethylmaleimide (irreversible) <clueType>results in</clueType> a complete <clueType>loss</clueType> of <corefTheme>DNA binding activity</corefTheme>.</clue>
</event>
<event id="E65">
<type class="Negative_regulation" />
<theme idref="E26" />
<cause idref="E61" />
<clue>Similarly, covalent modification of free sulfhydryl groups with diamide (reversible) or N-ethylmaleimide (irreversible) <clueType>results in</clueType> a complete <clueType>loss</clueType> of <corefTheme>DNA binding activity</corefTheme>.</clue>
</event>
<sentence id="S10">In contrast, mild oxidation with <term sem="Protein_molecule" id="T51" lex="glucose_oxidase">glucose oxidase</term> selectively inhibits <term sem="Protein_molecule" id="T52" lex="p75">p75</term> and <term sem="Protein_molecule" id="T53" lex="p85">p85</term> binding while not blocking <term sem="Protein_molecule" id="T54" lex="p50">p50</term> and <term sem="Protein_molecule" id="T55" lex="p55">p55</term> interactions.</sentence>
<event id="E41">
<type class="Protein_metabolism" />
<theme idref="T52" />
<clue>In contrast, mild <clueType>oxidation</clueType> with glucose oxidase selectively inhibits p75 and p85 binding while not blocking p50 and p55 interactions.</clue>
</event>
<event id="E66">
<type class="Protein_metabolism" />
<theme idref="T53" />
<clue>In contrast, mild <clueType>oxidation</clueType> with glucose oxidase selectively inhibits p75 and p85 binding while not blocking p50 and p55 interactions.</clue>
</event>
<event id="E67">
<type class="Protein_metabolism" />
<theme idref="T54" />
<clue>In contrast, mild <clueType>oxidation</clueType> with glucose oxidase selectively inhibits p75 and p85 binding while not blocking p50 and p55 interactions.</clue>
</event>
<event id="E68">
<type class="Protein_metabolism" />
<theme idref="T55" />
<clue>In contrast, mild <clueType>oxidation</clueType> with glucose oxidase selectively inhibits p75 and p85 binding while not blocking p50 and p55 interactions.</clue>
</event>
<event id="E69">
<type class="Positive_regulation" />
<theme idref="E41" />
<cause idref="T51" />
<clue>In contrast, mild oxidation <linkCause>with</linkCause> glucose oxidase selectively inhibits p75 and p85 binding while not blocking p50 and p55 interactions.</clue>
<comment>NO CLUETYPE</comment>
</event>
<event id="E70">
<type class="Positive_regulation" />
<theme idref="E66" />
<cause idref="T51" />
<clue>In contrast, mild oxidation <linkCause>with</linkCause> glucose oxidase selectively inhibits p75 and p85 binding while not blocking p50 and p55 interactions.</clue>
<comment>NO CLUETYPE</comment>
</event>
<event id="E71">
<type class="Positive_regulation" />
<theme idref="E67" />
<cause idref="T51" />
<clue>In contrast, mild oxidation <linkCause>with</linkCause> glucose oxidase selectively inhibits p75 and p85 binding while not blocking p50 and p55 interactions.</clue>
<comment>NO CLUETYPE</comment>
</event>
<event id="E72">
<type class="Positive_regulation" />
<theme idref="E68" />
<cause idref="T51" />
<clue>In contrast, mild oxidation <linkCause>with</linkCause> glucose oxidase selectively inhibits p75 and p85 binding while not blocking p50 and p55 interactions.</clue>
<comment>NO CLUETYPE</comment>
</event>
<event id="E43">
<type class="Binding" />
<theme idref="T52" />
<theme idref="A3" />
<clue>In contrast, mild oxidation with glucose oxidase selectively inhibits p75 and p85 <clueType>binding</clueType> while not blocking p50 and p55 interactions.</clue>
<comment>NO COREFTHEME for A3</comment>
</event>
<event id="E44">
<type class="Negative_regulation" />
<theme idref="E43" />
<cause idref="E41" />
<clue>In contrast, mild oxidation with glucose oxidase selectively <clueType>inhibits</clueType> p75 and p85 binding while not blocking p50 and p55 interactions.</clue>
</event>
<event id="E45">
<type class="Binding" />
<theme idref="T53" />
<theme idref="A3" />
<clue>In contrast, mild oxidation with glucose oxidase selectively inhibits p75 and p85 <clueType>binding</clueType> while not blocking p50 and p55 interactions.</clue>
<comment>NO COREFTHEME for A3</comment>
</event>
<event id="E46">
<type class="Negative_regulation" />
<theme idref="E45" />
<cause idref="E66" />
<clue>In contrast, mild oxidation with glucose oxidase selectively <clueType>inhibits</clueType> p75 and p85 binding while not blocking p50 and p55 interactions.</clue>
</event>
<event id="E48">
<type class="Binding" />
<theme idref="T54" />
<theme idref="A3" />
<clue>In contrast, mild oxidation with glucose oxidase selectively inhibits p75 and p85 binding while not blocking p50 and p55 <clueType>interactions</clueType>.</clue>
<comment>NO COREFTHEME for A3</comment>
</event>
<event assertion="non-exist" id="E49">
<type class="Negative_regulation" />
<theme idref="E48" />
<cause idref="E67" />
<clue>In contrast, mild oxidation with glucose oxidase selectively inhibits p75 and p85 binding while not <clueType>blocking</clueType> p50 and p55 interactions.</clue>
</event>
<event id="E51">
<type class="Binding" />
<theme idref="T55" />
<theme idref="A3" />
<clue>In contrast, mild oxidation with glucose oxidase selectively inhibits p75 and p85 binding while not blocking p50 and p55 <clueType>interactions</clueType>.</clue>
<comment>NO COREFTHEME for A3</comment>
</event>
<event assertion="non-exist" id="E52">
<type class="Negative_regulation" />
<theme idref="E51" />
<cause idref="E68" />
<clue>In contrast, mild oxidation with glucose oxidase selectively inhibits p75 and p85 binding while not <clueType>blocking</clueType> p50 and p55 interactions.</clue>
</event>
<sentence id="S11">These findings suggest that <term sem="Amino_acid_monomer" id="T56" lex="reduced_cysteine_thiol">reduced <term sem="Amino_acid_monomer" id="A4">cysteine</term> thiols</term> play an important role in the <term sem="Other" id="T57" lex="DNA_binding_activity"><term sem="DNA_domain_or_region" id="A5">DNA</term> binding activity</term> of this family of <term sem="Protein_family_or_group" id="T58" lex="Rel-related_transcription_factor">Rel-related transcription factors</term>.</sentence>
<event id="E53">
<type class="Metabolism" />
<theme idref="A4" />
<clue>These findings suggest that <clueType>reduced</clueType> cysteine <clueType>thiols</clueType> play an important role in the DNA binding activity of this family of Rel-related transcription factors.</clue>
</event>
<event id="E54">
<type class="Binding" />
<theme idref="A5" />
<theme idref="T58" />
<clue>These findings suggest that reduced cysteine thiols play an important role in the DNA <clueType>binding</clueType> activity <linkTheme>of</linkTheme> this family of Rel-related transcription factors.</clue>
</event>
<event id="E55">
<type class="Regulation" />
<theme idref="E54" />
<cause idref="E53" />
<clue>These findings suggest that reduced cysteine thiols <clueType>play</clueType> an important <clueType>role</clueType> <linkTheme>in</linkTheme> the DNA binding activity of this family of Rel-related transcription factors.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
